In the past two years, the Food and Drug Administration (FDA) and Pfizer have made several announcements on the drug Xeljanz. None of them have been good.
The FDA has reported on Xeljanz’s association with pulmonary embolisms, severe heart issues, cancer, and death. This comes nine years after the FDA approved it to treat psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Former Xeljanz patients have begun to file lawsuits against Pfizer. These Xelijanz lawsuits allege that the drug caused them to suffer severe side effects.